Hematopoietic stem cell transplantation in Niemann-Pick disease type B monitored by chitotriosidase activity.

Pediatr Blood Cancer 2018 Feb 1;65(2). Epub 2017 Nov 1.

Paediatric Onco-Haematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy.

Here, we report a patient with Niemann-Pick disease type B, with early severe onset of disease and pulmonary involvement, treated with hematopoietic stem cell transplant (HSCT) from a bone marrow matched unrelated donor. We confirm that HSCT is feasible and potentially beneficial for patients with severe phenotype. Noteworthy, we discussed the potential usefulness of the activity of peripheral chitotriosidase for the longitudinal evaluation of HSCT success and effectiveness.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26811DOI Listing
February 2018
4 Reads

Publication Analysis

Top Keywords

disease type
8
stem cell
8
niemann-pick disease
8
hematopoietic stem
8
unrelated donor
4
donor confirm
4
hsct feasible
4
feasible beneficial
4
matched unrelated
4
confirm hsct
4
marrow matched
4
treated hematopoietic
4
involvement treated
4
cell transplant
4
hsct bone
4
bone marrow
4
beneficial patients
4
phenotype noteworthy
4
longitudinal evaluation
4
chitotriosidase longitudinal
4

References

(Supplied by CrossRef)

Similar Publications